[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 3663 Introduced in Senate (IS)]

<DOC>






118th CONGRESS
  2d Session
                                S. 3663

 To provide funding for programs and activities under the SUPPORT for 
                     Patients and Communities Act.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            January 25, 2024

  Mrs. Shaheen (for herself and Ms. Hassan) introduced the following 
  bill; which was read twice and referred to the Committee on Health, 
                     Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
 To provide funding for programs and activities under the SUPPORT for 
                     Patients and Communities Act.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Turn the Tide Act''.

SEC. 2. CONTROLLED SUBSTANCE PROVISIONS OF THE SUPPORT FOR PATIENTS AND 
              COMMUNITIES ACT.

    (a) Grants To Enhance Access to Substance Use Disorder Treatment.--
Section 3203(b) of the Substance Use-Disorder Prevention that Promotes 
Opioid Recovery and Treatment for Patients and Communities Act (Public 
Law 115-271) is amended to read as follows:
    ``(b) Appropriations.--For grants under subsection (a), there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $4,000,000 for each 
of fiscal years 2024 through 2027.''.
    (b) Access to Increased Drug Disposal.--Section 3260 of the 
Substance Use-Disorder Prevention that Promotes Opioid Recovery and 
Treatment for Patients and Communities Act (Public Law 115-271) is 
amended to read as follows:

``SEC. 3260. APPROPRIATIONS.

    ``To carry out this chapter, there is authorized to be 
appropriated, and there is appropriated, out of any monies in the 
Treasury not otherwise appropriated, $10,000,000 for each of fiscal 
years 2024 through 2027.''.

SEC. 3. PUBLIC HEALTH PROVISIONS OF THE SUPPORT FOR PATIENTS AND 
              COMMUNITIES ACT.

    (a) First Responder Training.--Section 546(h) of the Public Health 
Service Act (42 U.S.C. 290ee-1(h)) is amended to read as follows:
    ``(h) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $56,000,000 for each 
of fiscal years 2024 through 2027.''.
    (b) Public Health Laboratories Pilot Program.--Section 7011(d) of 
the Substance Use-Disorder Prevention that Promotes Opioid Recovery and 
Treatment for Patients and Communities Act (Public Law 115-271) is 
amended to read as follows:
    ``(d) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $15,000,000 for each 
of fiscal years 2024 through 2027.''.
    (c) Model Training Programs for Substance Use Disorder Patient 
Records.--Section 7053(e) of the Substance Use-Disorder Prevention that 
Promotes Opioid Recovery and Treatment for Patients and Communities Act 
(Public Law 115-271) is amended to read as follows:
    ``(e) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated--
            ``(1) $4,000,000 for fiscal year 2024;
            ``(2) $2,000,000 for fiscal year 2025; and
            ``(3) $1,000,000 for each of fiscal years 2026 and 2027.''.
    (d) Residential Treatment Programs for Pregnant and Postpartum 
Women.--Section 508(s) of the Public Health Service Act (42 U.S.C. 
290bb-1(s)) is amended by striking the first sentence and inserting the 
following: ``To carry out this section, there is authorized to be 
appropriated, and there is appropriated, out of any monies in the 
Treasury not otherwise appropriated, $40,000,000 for each of fiscal 
years 2024 through 2027.''.
    (e) Mental and Behavioral Health Education and Training Grants.--
Section 756(f) of the Public Health Service Act (42 U.S.C. 294e-1(f)) 
is amended to read as follows:
    ``(f) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $75,000,000 for each 
of fiscal years 2024 through 2027.''.
    (f) Coordination and Continuation of Care for Drug Overdose 
Patients.--Section 7081(f) of the Substance Use-Disorder Prevention 
that Promotes Opioid Recovery and Treatment for Patients and 
Communities Act (Public Law 115-271) is amended to read as follows:
    ``(f) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $10,000,000 for each 
of fiscal years 2024 through 2027.''.
    (g) Emergency Department Alternatives to Opioids Demonstration 
Program.--Section 7091(g) of the Substance Use-Disorder Prevention that 
Promotes Opioid Recovery and Treatment for Patients and Communities Act 
(Public Law 115-271) is amended to read as follows:
    ``(g) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $10,000,000 for each 
of fiscal years 2024 through 2027.''.
    (h) Regional Centers of Excellence in Substance Use Disorder 
Education.--Section 551(f) of the Public Health Service Act (42 U.S.C. 
290ee-6(f)) is amended to read as follows:
    ``(f) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $4,000,000 for each 
of fiscal years 2024 through 2027.''.
    (i) Youth Prevention and Recovery.--Section 7102(c)(9) of the 
Substance Use-Disorder Prevention that Promotes Opioid Recovery and 
Treatment for Patients and Communities Act (Public Law 115-271) is 
amended to read as follows:
            ``(9) Appropriations.--To carry out this subsection, there 
        is authorized to be appropriated, and there is appropriated, 
        out of any monies in the Treasury not otherwise appropriated, 
        $18,000,000 for each of fiscal years 2024 through 2027.''.
    (j) Comprehensive Opioid Recovery Centers.--Section 552(j) of the 
Public Health Service Act (42 U.S.C. 290ee-7(j)) is amended to read as 
follows:
    ``(j) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $10,000,000 for each 
of fiscal years 2024 through 2027.''.
    (k) CDC Surveillance and Data Collection.--Section 7131(e) of the 
Substance Use-Disorder Prevention that Promotes Opioid Recovery and 
Treatment for Patients and Communities Act (Public Law 115-271) is 
amended to read as follows:
    ``(e) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $2,000,000 for each 
of fiscal years 2024 through 2027.''.
    (l) National Child Traumatic Stress Initiative.--Section 582(j) of 
the Public Health Service Act (42 U.S.C. 290hh-1(j)) is amended to read 
as follows:
    ``(j) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $112,000,000 for 
each of fiscal years 2024 through 2027.''.
    (m) Trauma Support Services and Mental Health Care.--Section 
7134(l) of the Substance Use-Disorder Prevention that Promotes Opioid 
Recovery and Treatment for Patients and Communities Act (Public Law 
115-271) is amended to read as follows:
    ``(l) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $50,000,000 for each 
of fiscal years 2024 through 2027.''.
    (n) Surveillance and Education Regarding Infections Associated With 
Illicit Drug Use and Other Risk Factors.--Section 317N(d) of the Public 
Health Service Act (42 U.S.C. 247b-15(d)) is amended to read as 
follows:
    ``(d) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $40,000,000 for each 
of fiscal years 2024 through 2027.''.
    (o) Building Communities of Recovery.--Section 547(f) of the Public 
Health Service Act (42 U.S.C. 290ee-2(f)) is amended to read as 
follows:
    ``(f) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $16,000,000 for each 
of fiscal years 2024 through 2027.''.
    (p) Peer Support Technical Assistance Center.--Section 547A(e) of 
the Public Health Service Act (42 U.S.C. 290ee-2a(e)) is amended to 
read as follows:
    ``(e) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $2,000,000 for each 
of fiscal years 2024 through 2027.''.
    (q) Preventing Overdoses of Controlled Substances.--Section 392A(d) 
of the Public Health Service Act (42 U.S.C. 280b-1(d)) is amended to 
read as follows:
    ``(d) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $506,000,000 for 
each of fiscal years 2024 through 2027.''.
    (r) Career Act.--Section 7183(k) of the Substance Use-Disorder 
Prevention that Promotes Opioid Recovery and Treatment for Patients and 
Communities Act (Public Law 115-271) is amended to read as follows:
    ``(k) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $12,000,000 for each 
of fiscal years 2024 through 2027.''.

SEC. 4. HOUSING AND DEPARTMENT OF JUSTICE PROVISIONS OF THE SUPPORT FOR 
              PATIENTS AND COMMUNITIES ACT.

    (a) Reauthorization and Improvement of Recovery Housing Program.--
Section 8071 of the SUPPORT for Patients and Communities Act (42 U.S.C. 
5301 note; Public Law 115-271) is amended--
            (1) in subsection (a), by striking ``such sums as may be 
        necessary for each of fiscal years 2019 through 2023'' and 
        inserting ``$60,000,000 for each of fiscal years 2024 through 
        2029'';
            (2) in subsection (b)--
                    (A) in paragraph (1), by striking ``date of 
                enactment of this Act'' and inserting ``date of 
                enactment of the Turn the Tide Act''; and
                    (B) by striking paragraph (2) and inserting the 
                following:
            ``(2) Priority.--
                    ``(A) In general.--The funding formula required 
                under paragraph (1) shall ensure that priority for 
                amounts appropriated or otherwise made available under 
                this section is given to States with the greatest need, 
                as such need is determined by the Secretary based on 
                the following factors, and weighting such factors as 
                described in subparagraph (B):
                            ``(i) The highest average rates of 
                        unemployment based on data provided by the 
                        Bureau of Labor Statistics for calendar years 
                        2019 through 2023.
                            ``(ii) The lowest average labor force 
                        participation rates based on data provided by 
                        the Bureau of Labor Statistics for calendar 
                        years 2019 through 2023.
                            ``(iii) The highest average age-adjusted 
                        rates of drug overdose deaths based on data 
                        from the Centers for Disease Control and 
                        Prevention for the 3 most recent calendar 
                        years.
                    ``(B) Weighting.--The factors described in 
                subparagraph (A) shall be weighted as follows:
                            ``(i) The rate described in subparagraph 
                        (A)(i) shall be weighted at 15 percent.
                            ``(ii) The rate described in subparagraph 
                        (A)(ii) shall be weighted at 15 percent.
                            ``(iii) The rate described in subparagraph 
                        (A)(iii) shall be weighted at 70 percent.''; 
                        and
            (3) in subsection (c)(1), by striking ``at least 30 percent 
        of such funds within one year'' and inserting ``at least 50 
        percent of such funds within 2 years''.
    (b) Building Capacity for Family-Focused Residential Treatment.--
Section 8083(c) of the Substance Use-Disorder Prevention that Promotes 
Opioid Recovery and Treatment for Patients and Communities Act (Public 
Law 115-271) is amended to read as follows:
    ``(c) Appropriations.--To carry out this section, there is 
authorized to be appropriated, and there is appropriated, out of any 
monies in the Treasury not otherwise appropriated, $20,000,000 for 
fiscal years 2024, which shall remain available through fiscal year 
2027.''.
    (c) Comprehensive Opioid Abuse Grant Program.--Section 1001(a)(27) 
of title I of the Omnibus Crime Control and Safe Streets Act of 1968 
(34 U.S.C. 10261(a)(27)) is amended to read as follows:
    ``(27) To carry out part LL, there is authorized to be 
appropriated, and there is appropriated, out of any monies in the 
Treasury not otherwise appropriated, $500,000,000 for each of fiscal 
years 2024 through 2027.''.
    (d) Office of National Drug Control Policy.--Section 714 of the 
Office of National Drug Control Policy Reauthorization Act of 1998 (21 
U.S.C. 1711) is amended to read as follows:

``SEC. 714. AUTHORIZATION OF APPROPRIATIONS; APPROPRIATIONS.

    ``To carry out this title, except activities otherwise specified, 
there is authorized to be appropriated, and there is appropriated, out 
of any monies in the Treasury not otherwise appropriated, $50,000,000 
for each of fiscal years 2024 through 2027, to remain available until 
expended.''.
    (e) Drug-Free Communities Program.--Section 1024 of the Anti-Drug 
Abuse Act of 1988 (21 U.S.C. 1524) is amended--
            (1) in the heading, by inserting ``; appropriations'' after 
        ``authorization of appropriations''; and
            (2) by striking subsection (a) and inserting the following:
    ``(a) In General.--To carry out this chapter, there is authorized 
to be appropriated to the Office of National Drug Control Policy, and 
there is appropriated, out of any monies in the Treasury not otherwise 
appropriated, $175,000,000 for each of fiscal years 2024 through 
2027.''.
    (f) High-Intensity Drug Trafficking Area Program.--Section 707(p) 
of the Office of National Drug Control Policy Reauthorization Act of 
1988 (21 U.S.C. 1706(p)) is amended--
            (1) by redesignating paragraphs (1) through (6) as 
        subparagraphs (A) through (F), respectively, and adjusting the 
        margins accordingly;
            (2) by striking ``There is authorized'' and inserting the 
        following:
            ``(1) In general.--There is authorized'';
            (3) in paragraph (1), as so designated--
                    (A) in subparagraph (E), as so redesignated, by 
                striking ``each of''; and
                    (B) in subparagraph (F), as so redesignated, by 
                striking ``2018 through 2023'' and inserting ``2024 
                through 2027''; and
            (4) by adding at the end the following:
            ``(2) Appropriations.--To carry out this section, there is 
        authorized to be appropriated to the Office of National Drug 
        Control Policy, and there is appropriated, out of any monies in 
        the Treasury not otherwise appropriated, $350,000,000 for each 
        of fiscal years 2024 through 2027.''.
    (g) Drug Court Program.--Section 1001(a)(25)(A) of title I of the 
Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 
10261(a)(25)(A)) is amended to read as follows:
    ``(25)(A) Except as provided in subparagraph (C), to carry out part 
EE, there is authorized to be appropriated, and there is appropriated, 
out of any monies in the Treasury not otherwise appropriated, 
$125,000,000 for each of fiscal years 2024 through 2027.''.
    (h) Drug Court Training and Technical Assistance.--Section 
705(e)(2) of the Office of National Drug Control Policy Reauthorization 
Act of 1988 (21 U.S.C. 1704(e)(2)) is amended to read as follows:
            ``(2) Authorization of appropriations; appropriations.--To 
        carry out this subsection, there is authorized to be 
        appropriated, and there is appropriated, out of any monies in 
        the Treasury not otherwise appropriated, $5,000,000 for each of 
        fiscal years 2024 through 2027.''.
    (i) Administration of the Office of National Drug Control Policy.--
Section 704(i)(2) of the Office of National Drug Control Policy 
Reauthorization Act of 1998 (21 U.S.C. 1703(i)(2)) is amended to read 
as follows:
            ``(2) Authorization of appropriations; appropriations.--To 
        carry out this subsection, there is authorized to be 
        appropriated, and there is appropriated, out of any monies in 
        the Treasury not otherwise appropriated, $1,750,000 for each of 
        fiscal years 2024 through 2027.''.
    (j) Emerging Threats Committee, Plan, and Media Campaign.--Section 
709(g) of the Office of National Drug Control Policy Reauthorization 
Act of 1998 (21 U.S.C. 1708(g)) is amended to read as follows:
    ``(g) Authorization of Appropriations; Appropriations.--To carry 
out this section, there is authorized to be appropriated to the Office, 
and there is appropriated, out of any monies in the Treasury not 
otherwise appropriated, $35,000,000 for each of fiscal years 2024 
through 2027.''.

SEC. 5. BOLSTERING COMMITMENTS TO STATE GRANTS FOR SUBSTANCE USE 
              DISORDER TREATMENT AND PREVENTION.

    (a) State Opioid Response Grants.--
            (1) In general.--To carry out activities under section 1003 
        of the 21st Century Cures Act (42 U.S.C. 290ee-3 note) relating 
        to opioids by the State agency responsible for administering 
        the substance abuse prevention and treatment block grant under 
        subpart II of part B of title XIX of the Public Health Service 
        Act (42 U.S.C. 300x-21 et seq.), there is authorized to be 
        appropriated, and there is appropriated, $5,500,000,000 for 
        each of fiscal years 2024 through 2028.
            (2) Flexibility in use of funds.--Section 1003(b) of the 
        21st Century Cures Act (42 U.S.C. 290ee-3 note) is amended by 
        adding at the end the following:
            ``(3) Flexibility.--States and Indian tribes may use 
        amounts provided under grants under this subsection to support 
        substance use disorder treatment care and related services 
        regardless of whether the patient involved has a primary 
        diagnosis of opioid use disorder, so long as the individual has 
        a substance use disorder diagnosis.
            ``(4) Rule of construction.--Nothing in this subsection 
        shall be construed to prohibit States from using grant funds 
        under this subsection to allocate amounts to local governments 
        to establish subgrantee awards in such localities.''.
            (3) Substance abuse prevention and treatment block 
        grants.--Section 1935(a) of the Public Health Service Act (42 
        U.S.C. 300x-35(a)) is amended to read as follows:
    ``(a) Appropriations.--To carry out this subpart, subpart III, and 
section 505(d), there is authorized to be appropriated, and there is 
appropriated, out of any monies in the Treasury not otherwise 
appropriated, $3,000,000,000 for each of fiscal years 2024 through 
2028, and $2,500,000,000 for each of fiscal years 2029 through 2033.''.
    (b) Requirements.--For the purposes of carrying out activities with 
amounts appropriated under this section (and the amendment made by this 
section), the Secretary of Health and Human Services shall ensure that 
the following requirements are complied with:
            (1) Of the amount appropriated for each fiscal year under 
        subsection (a) (and the amendment made by such subsection), 
        $50,000,000 shall be made available to Indian Tribes or tribal 
        organizations.
            (2) Of such remaining amounts for each such fiscal year, 15 
        percent shall be made available to the States with the highest 
        mortality rate related to opioid use disorders. For purposes of 
        allocating such funds, the Secretary shall develop a formula 
        that avoids a significant cliff between States with similar 
        mortality rates to prevent unusually large changes in certain 
        States when compared to prior year allocations, including 
        consideration of new formula methodologies to avoid such 
        funding cliffs.
            (3) Of the amount made available for each fiscal year under 
        subsections (a)(1) for State Opioid Response Grants, not more 
        than 2 percent of such amount shall be available for Federal 
        administrative expenses, training, technical assistance, and 
        evaluation.
            (4) Of the amounts not reserved under paragraphs (1) 
        through (3), the Secretary shall make allocations to States, 
        territories, and the District of Columbia according to a 
        formula using national survey results that the Secretary 
        determines are the most objective and reliable measure of drug 
        use and drug-related deaths.
            (5) The formula methodology under paragraph (4) shall be 
        submitted to the Committees on Appropriations of the House of 
        Representatives and the Committee on Appropriations of the 
        Senate not less than 15 days prior to publishing a Funding 
        Opportunity Announcement.
            (6) The prevention and treatment activities funded through 
        grants under this section may include education, treatment 
        (including the provision of medication), behavioral health 
        services for individuals in treatment programs, referral to 
        treatment services, recovery support, and medical screening 
        associated with such treatment.
            (7) Each State, including the District of Columbia, shall 
        receive not less than $4,000,000 under grants under this 
        section.
            (8) In addition to amounts appropriated under this section 
        (and the amendment made by this section), the following amounts 
        shall be available under section 241 of the Public Health 
        Service Act (42 U.S.C. 238j):
                    (A) $79,200,000 to carry out subpart II of part B 
                of title XIX of the Public Health Service Act to fund 
                section 1935(b) (42 U.S.C. 300x-35) (relating to 
                technical assistance, national data, data collection 
                and evaluation activities) and the total available 
                under this Act for activities under such section 
                1935(b) shall not exceed 5 percent of the amounts 
                appropriated for such subpart II of part B of title 
                XIX.
                    (B) $2,000,000 to evaluate substance abuse 
                treatment programs.
            (9) None of the funds provided for under section 1921 of 
        the Public Health Service Act (42 U.S.C. 300x-21) or State 
        Opioid Response Grants under section 1003 of the 21st Century 
        Cures Act (42 U.S.C. 290ee-3 note) shall be subject to section 
        241 of such Act (42 U.S.C. 238j).

SEC. 6. ELIMINATING INSURANCE BARRIERS TO MEDICATION-ASSISTED 
              TREATMENT.

    (a) Prohibition.--Section 1903(i) of the Social Security Act (42 
U.S.C. 1396b(i)) is amended--
            (1) in paragraph (26), by striking ``; or'' and inserting a 
        semicolon;
            (2) in paragraph (27), by striking the period at the end 
        and inserting ``; or''; and
            (3) by inserting after paragraph (27) the following new 
        paragraph:
            ``(28) with respect to any amount expended for medical 
        assistance for medication-assisted treatment (as defined in 
        section 1905(ee)) if the State imposes any utilization control 
        policies or procedures (as defined by the Secretary), including 
        any prior authorization requirements, with respect to the 
        provision of such assistance; or''.
    (b) Conforming Amendment.--Section 1905(a)(29) of the Social 
Security Act (42 U.S.C. 1396d(a)(29)) is amended by inserting ``and 
section 1903(i)(28)'' after ``subsection (ee)''.
    (c) Effective Date.--The amendments made by this subsection take 
effect on October 1, 2024.

SEC. 7. LIMITATIONS ON COST-SHARING FOR OPIOID OVERDOSE REVERSAL 
              MEDICATIONS.

    (a) Limitations on Cost-Sharing.--
            (1) Public health service act.--Part D of title XXVII of 
        the Public Health Service Act (42 U.S.C. 300gg-111 et seq.) is 
        amended by adding at the end the following:

``SEC. 2799A-11. LIMITATIONS ON COST-SHARING FOR OPIOID OVERDOSE 
              REVERSAL AGENTS.

    ``(a) In General.--A group health plan or a health insurance issuer 
offering group or individual health insurance coverage shall provide 
coverage for, and shall not impose any cost-sharing requirement under 
the plan or coverage with respect to at least one formulation of an 
opioid overdose reversal agent.
    ``(b) Utilization Control Policies; Medical Management.--A group 
health plan or health insurance issuer offering group or individual 
health insurance coverage shall not impose any utilization control 
policies or procedures (as defined by the Secretary), including prior 
authorization requirements, with respect to opioid overdose reversal 
agents covered under the plan or coverage. Such a plan or issuer may 
apply medical management practices in providing the benefits described 
in subsection (a).
    ``(c) Definition.--In this section, the term `opioid overdose 
reversal agent' means a drug or biological product approved by the Food 
and Drug Administration for one of the following uses (or a similar 
use):
            ``(1) Complete or partial reversal of opioid depression, 
        including respiratory depression, induced by opioids.
            ``(2) Emergency treatment of a known or suspected opioid 
        overdose, as manifested by respiratory or central nervous 
        system depression.''.
            (2) Employee retirement income security act of 1974.--
                    (A) In general.--Subpart B of part 7 of subtitle B 
                of title I of the Employee Retirement Income Security 
                Act of 1974 (29 U.S.C. 1185 et seq.) is amend by adding 
                at the end the following:

``SEC. 726. LIMITATIONS ON COST-SHARING FOR OPIOID OVERDOSE REVERSAL 
              AGENTS.

    ``(a) In General.--A group health plan or a health insurance issuer 
offering group health insurance coverage shall provide coverage for, 
and shall not impose any cost-sharing requirement under the plan or 
coverage with respect to at least one formulation of an opioid overdose 
reversal agent.
    ``(b) Utilization Control Policies; Medical Management.--A group 
health plan or health insurance issuer offering group health insurance 
coverage shall not impose any utilization control policies or 
procedures (as defined by the Secretary), including prior authorization 
requirements, with respect to opioid overdose reversal agents covered 
under the plan or coverage. Such a plan or issuer may apply medical 
management practices in providing the benefits described in subsection 
(a).
    ``(c) Definition.--In this section, the term `opioid overdose 
reversal agent' means a drug or biological product approved by the Food 
and Drug Administration for one of the following uses (or a similar 
use):
            ``(1) Complete or partial reversal of opioid depression, 
        including respiratory depression, induced by opioids.
            ``(2) Emergency treatment of a known or suspected opioid 
        overdose, as manifested by respiratory or central nervous 
        system depression.''.
                    (B) Clerical amendment.--The table of contents in 
                section 1 of the Employee Retirement Income Security 
                Act of 1974 (29 U.S.C. 1001 et seq.) is amended by 
                inserting after the item relating to section 725 the 
                following new item:

``Sec. 726. Limitations on cost-sharing for opioid overdose reversal 
                            agents.''.
            (3) Internal revenue code of 1986.--
                    (A) In general.--Subchapter B of chapter 100 of the 
                Internal Revenue Code of 1986 is amended by adding at 
                the end the following:

``SEC. 9826. LIMITATIONS ON COST-SHARING FOR OPIOID OVERDOSE REVERSAL 
              AGENTS.

    ``(a) In General.--A group health plan shall provide coverage for, 
and shall not impose any cost-sharing requirement under the plan with 
respect to at least one formulation of an opioid overdose reversal 
agent.
    ``(b) Utilization Control Policies; Medical Management.--A group 
health plan shall not impose any utilization control policies or 
procedures (as defined by the Secretary), including prior authorization 
requirements, with respect to opioid overdose reversal agents covered 
under the plan. Such a plan may apply medical management practices in 
providing the benefits described in subsection (a).
    ``(c) Definition.--In this section, the term `opioid overdose 
reversal agent' means a drug or biological product approved by the Food 
and Drug Administration for one of the following uses (or a similar 
use):
            ``(1) Complete or partial reversal of opioid depression, 
        including respiratory depression, induced by opioids.
            ``(2) Emergency treatment of a known or suspected opioid 
        overdose, as manifested by respiratory or central nervous 
        system depression.''.
                    (B) Clerical amendment.--The table of sections for 
                subchapter B of chapter 100 of the Internal Revenue 
                Code of 1986 is amended by adding at the end the 
                following new item:

``Sec. 9826. Limitations on cost-sharing for opioid overdose reversal 
                            agents.''.
            (4) Effective date.--The amendments made by this subsection 
        shall apply to plan years beginning on or after January 1, 
        2025.
    (b) Safe Harbor for Absence of Deductible for Opioid Overdose 
Reversal Agents.--
            (1) In general.--Paragraph (2) of section 223(c) of the 
        Internal Revenue Code of 1986 is amended by adding at the end 
        the following new subparagraph:
                    ``(H) Safe harbor for absence of deductible for 
                opioid overdose reversal agents.--A plan shall not fail 
                to be treated as a high deductible health plan by 
                reason of failing to have a deductible for opioid 
                overdose reversal agents (as defined in section 
                9826(c)).''.
            (2) Effective date.--The amendment made by this section 
        shall apply to plan years beginning on or after January 1, 
        2025.
    (c) Limitations on Cost-Sharing Under Medicare Part D.--
            (1) In general.--Section 1860D-2 of the Social Security Act 
        (42 U.S.C. 1395w-102) is amended--
                    (A) in subsection (b)--
                            (i) in paragraph (1)(A), in the matter 
                        preceding clause (i), by striking ``and (9)'' 
                        and inserting ``, (9), and (10)'';
                            (ii) in paragraph (2)(A), in the matter 
                        preceding clause (i), by striking ``and (9)'' 
                        and inserting ``, (9), and (10)''; and
                            (iii) by adding at the end the following 
                        new paragraph:
            ``(10) Limitations on cost-sharing for opioid overdose 
        reversal agents.--
                    ``(A) In general.--For plan year 2025 and each 
                subsequent plan year, each prescription drug plan and 
                MA-PD plan shall not impose any cost-sharing 
                requirement under the plan with respect to at least one 
                brand or generic version of an opioid overdose reversal 
                agent (as defined in section 2799A-11 of the Public 
                Health Service Act). The requirement under the 
                preceding sentence shall also apply to cost-sharing 
                applicable to subsidy eligible individuals under 
                section 1814D-14.
                    ``(B) Cost-sharing.--For purposes of subparagraph 
                (A), the elimination of cost-sharing shall include the 
                following:
                            ``(i) No application of deductible.--The 
                        waiver of the deductible under paragraph (1).
                            ``(ii) No application of coinsurance.--The 
                        waiver of coinsurance under paragraph (2).''; 
                        and
                    (B) in subsection (c), by adding at the end the 
                following new paragraph:
            ``(7) Treatment of cost-sharing for opioid overdose 
        reversal agents.--The coverage is provided in accordance with 
        subsection (b)(10).''.
            (2) Conforming amendments to cost-sharing for low-income 
        individuals.--Section 1860D-14(a) of the Social Security Act 
        (42 U.S.C. 1395w-114(a)) is amended--
                    (A) in paragraph (1), in the matter preceding 
                subparagraph (A), by striking ``In the case'' and 
                inserting ``Subject to section 1860D-2(b)(10), in the 
                case''; and
                    (B) in paragraph (2), in the matter preceding 
                subparagraph (A), by striking ``In the case'' and 
                inserting ``Subject to section 1860D-2(b)(10), in the 
                case''.

SEC. 8. TARGETING HEALTH WORKFORCE LOAN REPAYMENT ASSISTANCE TO 
              HARDEST-HIT STATES.

    (a) Loan Repayment Program for Substance Use Disorder Treatment 
Workforce.--Section 781 of the Public Health Service Act (42 U.S.C. 
295h) is amended--
            (1) in subsection (b), by adding at the end the following:
            ``(3) Tax liability.--The amount of a payment made under 
        this section on behalf of an individual shall not be considered 
        income for any purpose under the Internal Revenue Code of 
        1986.''; and
            (2) in subsection (j), by striking ``$25,000,000 for each 
        of fiscal years 2019 through 2023'' and inserting ``$50,000,000 
        for each of fiscal years 2024 through 2028''.
    (b) Training Demonstration Program.--Section 760(g) of the Public 
Health Service Act (42 U.S.C. 294k(g)) is amended to read as follows:
    ``(g) Appropriations.--
            ``(1) In general.--To carry out this section (other than 
        paragraph (2)), there is authorized to be appropriated, and 
        there is appropriated, out of any monies in the Treasury not 
        otherwise appropriated, $10,000,000 for each of fiscal years 
        2024 through 2027.
            ``(2) States with highest drug overdose death rates.--
                    ``(A) In general.--To carry out the program under 
                this section with respect to grantees located in States 
                described in subparagraph (B), there is authorized to 
                be appropriated, and there is appropriated, out of any 
                monies in the Treasury not otherwise appropriated, 
                $20,000,000 for each of fiscal years 2024 through 2027.
                    ``(B) States described.--A State described in this 
                subparagraph is a State that is among the top 10 States 
                in terms of highest per capita drug poisoning deaths in 
                each of calendar years 2019, 2020, and 2021, based on 
                the most recent data available from the Centers for 
                Disease Control and Prevention.
                    ``(C) Application of section.--Except as provided 
                in this paragraph, the requirements of this section 
                otherwise applicable to grantees under this section 
                shall apply to grantees receiving assistance under this 
                paragraph.''.

SEC. 9. MEDICAID PAYMENTS FOR BEHAVIORAL HEALTH AND MENTAL HEALTH 
              PROVIDERS.

    (a) In General.--
            (1) Fee-for-service.--Section 1902 of the Social Security 
        Act (42 U.S.C. 1396a) is amended--
                    (A) in subsection (a)(13)--
                            (i) by striking ``and'' at the end of 
                        subparagraph (B);
                            (ii) by adding ``and'' at the end of 
                        subparagraph (C); and
                            (iii) by adding at the end the following 
                        new subparagraph:
                    ``(D) payment for mental health and behavioral 
                health services (as defined in subsection (uu)(1)) 
                furnished on or after October 1, 2024, and before 
                October 1, 2028, by a physician or applicable 
                professional (as defined in subsection (uu)(2)) at a 
                rate that is not less than 100 percent of the payment 
                rate that applies to such services and physician or 
                applicable professional under part B of title XVIII 
                (or, if greater, the payment rate that would be 
                applicable under such part if the conversion factor 
                under section 1848(d) for the year involved were the 
                conversion factor under such section for 2024, and, if 
                such services are not covered under such part, the 
                reasonable and customary rate the Secretary determines 
                would apply to such services and physician or 
                applicable professional);''; and
                    (B) by adding at the end the following new 
                subsection:
    ``(uu) Mental Health and Behavioral Health Services.--For purposes 
of subsection (a)(13)(D):
            ``(1) Mental health and behavioral health services.--
                    ``(A) In general.--The term `mental health and 
                behavioral health services' means the following 
                services, when provided to a patient with a diagnosis 
                of substance use disorder (as defined in subparagraph 
                (B)) as a part of the management or treatment of the 
                patient's substance use disorder (as determined in 
                accordance with regulations promulgated by the 
                Secretary under subparagraph (C)):
                            ``(i) Evaluation and management services 
                        that are procedure codes (for services covered 
                        under title XVIII) for services in the category 
                        designated Evaluation and Management in the 
                        Healthcare Common Procedure Coding System 
                        (established by the Secretary under section 
                        1848(c)(5) as of December 31, 2020, and as 
                        subsequently modified).
                            ``(ii) Counseling services, as defined by 
                        the Secretary.
                            ``(iii) Payment codes established by the 
                        Secretary for opioid use disorder treatment 
                        services under section 1866F.
                            ``(iv) Any other services the Secretary 
                        determines are necessary for the management or 
                        treatment of a patient with a diagnosis of 
                        substance use disorder.
                    ``(B) Patient with a diagnosis of substance use 
                disorder.--For purposes of subparagraph (A), the term 
                `patient with a diagnosis of substance use disorder' 
                means an individual who has been diagnosed with 1 or 
                more diagnosis codes within the code set entitled the 
                `Mental health and behavioral disorders due to 
                psychoactive substance use' under the 10th revision of 
                the International Statistical Classification of 
                Diseases and Related Health Problems.
                    ``(C) Regulations.--Not later than 90 days after 
                the enactment of this subsection, the Secretary shall 
                promulgate regulations regarding when services are 
                sufficiently related to part of the management or 
                treatment of a patient's substance use disorder.
            ``(2) Applicable professional.--The term `applicable 
        professional' means--
                    ``(A) a clinical psychologist (as defined for 
                purposes of section 1861(ii));
                    ``(B) a clinical social worker (as defined in 
                section 1861(hh)(1));
                    ``(C) a medical professional approved to furnish 
                medication-assisted treatment under section 303(g)(2) 
                of the Controlled Substances Act; or
                    ``(D) a medical professional that is authorized 
                under the State plan or under a waiver of such plan to 
                furnish mental and behavioral health services (as 
                defined in paragraph (1)).''.
            (2) Managed care.--Section 1932(f) of such Act (42 U.S.C. 
        1396u-2(f)) is amended--
                    (A) in the subsection heading, by inserting ``and 
                Mental Health and Behavioral Health Services'' after 
                ``Care Services''; and
                    (B) by inserting before the period at the end the 
                following: ``, and, in the case of mental health and 
                behavioral health services described in section 
                1902(a)(13)(D), consistent with the minimum payment 
                rates specified in such section (regardless of the 
                manner in which such payments are made, including in 
                the form of capitation or partial capitation)''.
    (b) Increased FMAP for Additional Costs.--Section 1905 of the 
Social Security Act (42 U.S.C. 1396d) is amended--
            (1) in subsection (b), by striking ``and (ii)'' and 
        inserting ``(ii), and (jj)''; and
            (2) by adding at the end the following new subsection:
    ``(jj) Increased FMAP for Additional Expenditures for Mental Health 
and Behavioral Health Services.--
            ``(1) In general.--Notwithstanding subsection (b), with 
        respect to the portion of the amounts expended for medical 
        assistance for services described in section 1902(a)(13)(D) 
        furnished on or after October 1, 2024, and before October 1, 
        2028, that is attributable to the amount by which the minimum 
        payment rate required under such section (or, by application, 
        section 1932(f)) exceeds the payment rate applicable to such 
        services under the State plan or a waiver of such plan as of 
        July 1, 2024, the Federal medical assistance percentage for a 
        State shall be equal to 100 percent. The preceding sentence 
        shall not be construed as prohibiting the payment of Federal 
        financial participation based on the Federal medical assistance 
        percentage for the portion of the amounts expended for medical 
        assistance for such services that is attributable to the amount 
        (if any) by which the payment rate applicable to such services 
        under the State plan or waiver exceeds such minimum payment 
        rate.
            ``(2) Disregard of enhanced payments for purposes of 
        territorial limits.--The amount of any payment made for 
        expenditures on medical assistance that is attributable to the 
        application of the Federal medical assistance percentage 
        described in paragraph (1) shall not be taken into account for 
        purposes of applying payment limits under subsections (f) and 
        (g) of section 1108.''.

SEC. 10. CMI DEMONSTRATION TO TEST THE PROVISION OF RECOVERY HOUSING 
              FOR INDIVIDUALS WITH OPIOID USE DISORDER UNDER MEDICAID.

    Section 1115A of the Social Security Act (42 U.S.C. 1315a) is 
amended--
            (1) in subsection (b)(2)(A), by adding at the end the 
        following new sentence: ``The models selected under this 
        subparagraph shall include the demonstration described in 
        subsection (h) (which shall be implemented not later than 18 
        months after the date of enactment of such subsection).''; and
            (2) by adding at the end the following new subsection:
    ``(h) Demonstration To Test the Provision of Recovery Housing for 
Individuals With Opioid Use Disorder Under Medicaid.--
            ``(1) In general.--The CMI, in consultation with the 
        Secretary of Housing and Urban Development and other agencies, 
        as the Secretary determines appropriate, shall conduct a 
        demonstration project (referred to in this subsection as the 
        `demonstration') to test whether providing Medicaid managed 
        care entities with an elevated global capitated budget for 
        eligible Medicaid beneficiaries, paired with flexibilities to 
        allow States to provide medical assistance for recovery housing 
        for such beneficiaries, would result in reduced emergency 
        department visits, hospitalizations, and program expenditures 
        under per beneficiary, or improve quality of care for the such 
        beneficiaries without increasing expenditures under the 
        Medicaid program under title XIX.
            ``(2) Demonstration requirements.--
                    ``(A) In general.--Under the demonstration, each 
                eligible State that is selected by the CMI to 
                participate in the demonstration shall enter into an 
                agreement with a Medicaid managed care entity under 
                which the entity agrees to provide services (including 
                recovery housing) to eligible Medicaid beneficiaries 
                under a payment model that meets the requirements of 
                subparagraph (B).
                    ``(B) Capitated payments.--
                            ``(i) In general.--The CMI shall establish 
                        a capitated payments system for Medicaid 
                        managed care entities under the demonstration 
                        that is based on the demonstration budget 
                        determined under clause (ii).
                            ``(ii) Demonstration budget.--
                                    ``(I) In general.--For purposes of 
                                clause (i), the demonstration budget of 
                                a Medicaid managed care entity for each 
                                year of a demonstration period shall be 
                                determined by the CMI based on the 
                                number of eligible Medicaid 
                                beneficiaries enrolled with the entity 
                                and the average annual spending under 
                                title XIX in the State involved on 
                                individuals who are enrolled in the 
                                State plan under such title (or a 
                                waiver of such plan) and who--
                                            ``(aa) have a diagnosis of 
                                        opioid use disorder;
                                            ``(bb) are in the top 
                                        quartile of per beneficiary 
                                        spending for such plan or 
                                        waiver for the most recent 
                                        year; and
                                            ``(cc) have attained age 21 
                                        but have not attained age 65.
                                    ``(II) Risk adjustment.--The CMI 
                                may adjust the demonstration budget 
                                determined for a Medicaid managed care 
                                entity and a year under this clause 
                                using a risk adjustment model selected 
                                by the CMI to account for differences 
                                in age and clinical conditions of the 
                                eligible Medicaid beneficiaries 
                                enrolled with the entity compared to 
                                the overall population upon which the 
                                demonstration budget is based.
                    ``(C) Selection of eligible states.--Not later than 
                1 year after the date of enactment of this subsection, 
                the CMI shall select not less than 2 eligible States to 
                participate in the demonstration.
            ``(3) Additional waiver authority.--In addition to the 
        authority described in subsection (d)(1), the Secretary may 
        waive such requirements of title XIX as necessary to carry out 
        the demonstration.
            ``(4) Definitions.--In this subsection:
                    ``(A) Eligible medicaid beneficiary.--The term 
                `eligible Medicaid beneficiary' means an individual 
                who--
                            ``(i) is eligible for medical assistance 
                        under a State plan under title XIX or a waiver 
                        of such a plan;
                            ``(ii) has a diagnosis of opioid use 
                        disorder;
                            ``(iii) does not have a permanent residence 
                        (as certified by the individual);
                            ``(iv) is currently receiving medication-
                        assisted treatment or completed a course of 
                        medication-assisted treatment during the 3-
                        month period preceding the individual's 
                        participation in the demonstration; and
                            ``(v) has attained age 21 but has not 
                        attained age 65.
                    ``(B) Eligible state.--
                            ``(i) In general.--The term `eligible 
                        State' means a State that--
                                    ``(I) makes medical assistance 
                                available to all individuals described 
                                in section 1902(a)(10)(A)(i)(VIII); and
                                    ``(II) agrees to participate in the 
                                demonstration.
                            ``(ii) Selection of eligible states.--In 
                        selecting eligible States to participate in the 
                        demonstration, the CMI shall give priority to 
                        States that are--
                                    ``(I) among the top 10 States in 
                                terms of highest per capita drug 
                                poisoning deaths in each of calendar 
                                years 2019, 2020, and 2021, based on 
                                the most recent data available from the 
                                Centers for Disease Control and 
                                Prevention; and
                                    ``(II) among the 10 States with the 
                                lowest physician reimbursement rates 
                                for services furnished under title XIX 
                                (as determined by the Secretary) in 
                                each of calendar years 2019, 2020, and 
                                2021.
                    ``(C) Managed care entity.--The term `managed care 
                entity' means a medicaid managed care organization 
                described in section 1932(a)(1)(B)(i).
                    ``(D) Recovery housing.--The term `recovery 
                housing' means a shared living environment free from 
                alcohol and illicit drug use and centered on peer 
                support and connection to services that promote 
                sustained recovery from substance use disorders.
                    ``(E) State.--The term `State' includes the 50 
                States and the District of Columbia.''.

SEC. 11. EXTENSION OF MEDICAID DELIVERY SYSTEM REFORM AND INCENTIVE 
              PAYMENT WAIVERS.

    (a) Extension of Waivers.--In the case of a Medicaid section 1115 
waiver described in subsection (b), not later than 60 days after the 
date of enactment of this Act, the Secretary of Health and Human 
Services shall--
            (1) extend the termination date for the waiver to December 
        31, 2026 (or such earlier date as the State conducting the 
        waiver may elect);
            (2) apply the same annual dollar allotment for the period 
        for which the waiver is extended under paragraph (1) as the 
        annual dollar allotment that applied to the waiver period in 
        effect on the date of enactment of this Act; and
            (3) allow any State with such a waiver to use funds 
        provided during the period for which the waiver is extended 
        under paragraph (1) to support the training of direct service 
        workers that provide home and community-based services.
    (b) Medicaid Section 1115 Waiver Described.--The Medicaid section 
1115 waiver described in this subsection is a waiver approved under 
section 1115 of the Social Security Act (42 U.S.C. 1315) relating to 
delivery system reform incentive payments that--
            (1) as of the date of enactment of this Act, is to 
        terminate on or before December 31, 2024;
            (2) was in effect as of January 1, 2022; and
            (3) was approved for any State that is among the top 10 
        States in terms of highest per capita drug poisoning deaths in 
        each of calendar years 2019, 2020, and 2021, based on the most 
        recent data available from the Centers for Disease Control and 
        Prevention.

SEC. 12. EXPANDING DRUG-FREE COMMUNITIES SUPPORT GRANTS.

    Section 1032 of the Anti-Drug Abuse Act of 1988 (21 U.S.C. 1532) is 
amended--
            (1) in subsection (b)--
                    (A) in paragraph (3)--
                            (i) in subparagraph (A), by striking 
                        ``subparagraph (F)'' and inserting 
                        ``subparagraph (H)'';
                            (ii) by redesignating subparagraphs (D), 
                        (E), and (F) as subparagraphs (F), (G), and 
                        (H), respectively;
                            (iii) by inserting after subparagraph (C) 
                        the following:
                    ``(D) Subsequent additional grants.--Subject to 
                subparagraph (H), the Administrator may award a 
                subsequent additional grant to a grant recipient under 
                subparagraph (A), for each fiscal year during the 4-
                fiscal-year period following the fiscal year for which 
                the initial additional grant under subparagraph (A) is 
                awarded, in an amount not to exceed the amount of non-
                Federal funds, including in-kind contributions, raised 
                by the grant recipient for the fiscal year for which 
                the subsequent additional grant is awarded.
                    ``(E) Renewal grants.--Subject to subparagraph (H), 
                the Administrator may award a renewal grant to a grant 
                recipient under subparagraph (D), for the first fiscal 
                year following the 4-fiscal-year period for which the 
                subsequent additional grant under subparagraph (D) is 
                awarded, in an amount not to exceed the amount of non-
                Federal funds, including in-kind contributions, raised 
                by the grant recipient for the fiscal year for which 
                the renewal grant is awarded.''; and
                            (iv) in subparagraph (F), as so 
                        redesignated--
                                    (I) in the subparagraph heading, by 
                                striking ``renewal'' and inserting 
                                ``subsequent renewal''; and
                                    (II) in the matter preceding clause 
                                (i)--
                                            (aa) by striking ``clause 
                                        (iv)'' and inserting 
                                        ``subparagraph (H)'';
                                            (bb) by striking ``renewal 
                                        grant to a grant recipient 
                                        under this subparagraph'' and 
                                        inserting ``subsequent renewal 
                                        grant to a grant recipient 
                                        under subparagraph (E)''; and
                                            (cc) by striking ``initial 
                                        additional grant'' and 
                                        inserting ``renewal grant under 
                                        subparagraph (E)''; and
                    (B) in paragraph (4), by striking ``(3)(E)'' and 
                inserting ``(3)(G)'';
            (2) in subsection (d)--
                    (A) by striking ``In awarding'' and inserting the 
                following:
            ``(1) Priority for economically disadvantaged areas.--In 
        awarding''; and
                    (B) by adding at the end the following:
            ``(2) Priority for states demonstrating high mortality 
        rates relating to opioid use disorder.--
                    ``(A) Grants to more than 1 eligible coalition 
                representing a community.--In awarding grants under 
                subsection (b)(1)(B)(ii), the Administrator shall give 
                priority to eligible coalitions that serve 1 or more 
                communities in a State that has a high mortality rate 
                relating to opioid use disorder.
                    ``(B) Subsequent additional grants.--In awarding 
                subsequent additional grants under subsection 
                (b)(3)(D), the Administrator shall give priority to an 
                eligible coalition that serves 1 or more communities in 
                a State that has a high mortality rate relating to 
                opioid use disorder.''; and
            (3) by adding at the end the following:
    ``(e) Limitation on Subsequent Renewal Grants.--A recipient of a 
subsequent renewal grant awarded under subsection (b)(3)(F) may not be 
awarded any further grant under this section.''.

SEC. 13. SUPPORT FOR LAW ENFORCEMENT MENTAL HEALTH AND WELLNESS.

    There is authorized to be appropriated, and there is appropriated, 
out of any monies in the Treasury not otherwise appropriated, 
$15,000,000 for each of fiscal years 2024 through 2027 for grants under 
section 1701(b)(23) of title I of the Omnibus Crime Control and Safe 
Streets Act of 1968 (34 U.S.C. 10381(b)(23)) to establish peer 
mentoring mental health and wellness pilot programs within State, 
Tribal, and local law enforcement agencies.

SEC. 14. ADVERSE CHILDHOOD EXPERIENCES RESPONSE TEAM GRANT PROGRAM.

    (a) In General.--Title I of the Omnibus Crime Control and Safe 
Streets Act of 1968 (34 U.S.C. 10101 et seq.) is amended by adding at 
the end the following:

  ``PART PP--ADVERSE CHILDHOOD EXPERIENCES RESPONSE TEAM GRANT PROGRAM

``SEC. 3061. GRANTS FOR ADVERSE CHILDHOOD EXPERIENCES RESPONSE TEAMS.

    ``(a) Grants Authorized.--From amounts made available to carry out 
this section, the Attorney General, in coordination with the Secretary 
of Health and Human Services, shall make grants to States, units of 
local government, Indian Tribes, and neighborhood or community-based 
organizations to address adverse childhood experiences associated with 
exposure to trauma.
    ``(b) Use of Funds.--Amounts received under a grant under this 
section may be used to establish an adverse childhood experiences 
response team, including by--
            ``(1) establishing protocols to follow when encountering a 
        child or youth exposed to trauma to facilitate access to 
        services;
            ``(2) developing referral partnership agreements with 
        behavioral health providers, substance treatment facilities, 
        and recovery services for family members of children exposed to 
        trauma;
            ``(3) integrating law enforcement, mental health, and 
        crisis services to respond to situations where children have 
        been exposed to trauma;
            ``(4) implementing comprehensive programs and practices to 
        support children exposed to trauma;
            ``(5) identifying barriers for children to access trauma-
        informed care in their communities;
            ``(6) providing training in trauma-informed care to 
        emergency response providers, victim service providers, child 
        protective service professionals, educational institutions, and 
        other community partners;
            ``(7) supporting cross-system planning and collaboration 
        among officers and employees who work in law enforcement, court 
        systems, child welfare services, correctional reentry programs, 
        emergency medical services, health care services, public 
        health, and substance abuse treatment and recovery support; and
            ``(8) providing technical assistance to communities, 
        organizations, and public agencies on how to prevent and 
        mitigate the impact of exposure to trauma and violence.
    ``(c) Application.--A State, unit of local government, Indian 
Tribe, or neighborhood or community-based organization desiring a grant 
under this section shall submit to the Attorney General an application 
in such form, and containing such information, as the Attorney General 
may reasonably require.''.
    (b) Authorization of Appropriations.--Section 1001(a) of title I of 
the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 
10261(a)) is amended by adding at the end the following:
    ``(29) There are authorized to be appropriated to carry out part PP 
$10,000,000 for each of fiscal years 2024 through 2027.''.
                                 <all>